ATOSSA THERAPEUTICS, INC. Intangible Assets, Net (Excluding Goodwill)
ATOSSA THERAPEUTICS, INC. (ATOS) had Intangible Assets, Net (Excluding Goodwill) of $54.00 thousand as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2022-02-28
- 2021-12-31: Intangible Assets, Net (Excluding Goodwill) $54.00K.
- 2020-12-31: Intangible Assets, Net (Excluding Goodwill) $41.00K; Intangible Assets, Net (Excluding Goodwill) as first filed $53.50K.
- 2019-12-31: Intangible Assets, Net (Excluding Goodwill) $173.50K; Intangible Assets, Net (Excluding Goodwill) as first filed $174.00K.
- 2018-12-31: Intangible Assets, Net (Excluding Goodwill) $192.00K.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2021-12-31 | $54.00K 10-K · filed 2022-02-28 | |
| 2020-12-31 | $41.00K 10-K · filed 2022-02-28 | $53.50K 10-K · filed 2021-03-31 |
| 2019-12-31 | $173.50K 10-K · filed 2021-03-31 | $174.00K 10-K · filed 2020-03-26 |
| 2018-12-31 | $192.00K 10-K · filed 2020-03-26 | |
| 2017-12-31 | $234.00K 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |